HB3075
View on ILGACOSMETOLOGY PRODUCTS HEALTH
What this bill does
Creates the Illinois Health and Safety in Cosmetology and Barbering Products Disclosure Act. Requires the posting of health risk information and the provision of a pamphlet, with specific requirements. Requires the Department of Public Health to develop a posted notice and pamphlet that comply with the Act and make them available for download. Provides that the Department is responsible for monitoring compliance and making inspections. Denotes a petty offense as a penalty for violation. Exempts individuals or businesses who do not sell or use chemical products. Defines terms.
Calculating prediction drivers...
Pipeline Progress
Current stage: Floor Vote · Last action 409 days ago · STAGNANT
How does a bill become law in Illinois?
-
Introduction of Bill
A member of the Senate or the House introduces a bill, which is assigned a unique identifying number (e.g., "H.B. ___" for House bills and "S.B. ___" for Senate bills). If not enacted, it must be reintroduced in the next General Assembly with a new number.
-
Committee Work — Hearings
The bill goes to the appropriate committee, which holds hearings to gather expert opinions and determine the need for the legislation.
-
Committee Work — Markup, Amendments, Report
The committee may make amendments to the bill. If approved, a committee report endorsing the bill is issued.
-
Floor Debate
The bill is debated and can be further amended. The debate transcripts are accessible online for public viewing.
-
Passage and Consideration in Second Chamber
If the bill passes in the first chamber, it moves to the second chamber for a similar review process. If both chambers approve, it goes to the governor.
-
Gubernatorial Action
The governor can sign the bill into law, veto it, or take no action (resulting in an automatic law after 60 days). The type of veto can be total or amendatory. Once signed, the bill becomes a Public Act and is assigned a Public Act number.
Sponsor Context
Witness slips
2 slips filed. Proponent / opponent / no position as filed with the committee.
| Name | Organization | Representing | Position | Hearing committee | Hearing date |
|---|---|---|---|---|---|
| Dan Lewis | Illinois Department of Financial and Professional Regulation | Illinois Department of Financial and Professional Regulation | No Position On Merits | Public Health | 2025-03-20 |
| Dan Lewis | Illinois Department of Financial and Professional Regulation | Illinois Department of Financial and Professional Regulation | No Position On Merits | Public Health | 2025-03-13 |
Roll-call votes
Total votes and outcome per event. Deciding vote = margin of 1; those voters on the winning side could have changed the outcome by flipping.
| Date | Chamber | Type | Description | Yea | Nay | Present | NV | Outcome | Margin | Deciding voters |
|---|---|---|---|---|---|---|---|---|---|---|
| H | Committee | Public Health | 6 | 3 | 0 | 0 | Passed | 3 | — |
Action History
16 actions recorded. Last action: 2025-04-11 — Rule 19(a) / Re-referred toRules Committee. Each action's meaning and outcome signal are classified automatically.
All actions (table)
| Date | Chamber | Action | Category | Signal |
|---|---|---|---|---|
| 2025-02-06 | House | Filed with the Clerk byRep. Sonya M. Harper House Rule 6(b) | Introduction & Filing | — |
| 2025-02-06 | House | First Reading Senate Rule 5-1(d)/5-2; House Rule 37(d)/38 | Introduction & Filing | — |
| 2025-02-06 | House | Referred toRules Committee Senate Rule 3-8(a); House Rule 18(a) | Committee Assignment | — |
| 2025-03-04 | House | Assigned toPublic Health Committee Senate Rule 3-8(a); House Rule 18(b) | Committee Assignment | — |
| 2025-03-19 | House | Added Co-SponsorRep. Lisa Davis Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-03-19 | House | Added Co-SponsorRep. Kimberly Du Buclet Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-03-19 | House | Added Chief Co-SponsorRep. Debbie Meyers-Martin Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-03-19 | House | Added Chief Co-SponsorRep. Laura Faver Dias Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-03-19 | House | Added Chief Co-SponsorRep. Yolonda Morris Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-03-19 | House | Added Chief Co-SponsorRep. Lilian Jiménez Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-03-20 | House | Do Pass / Short DebatePublic Health Committee; 006-003-000 Senate Rule 3-11(a)(1); House Rule 22(a)(1), 52(b) | Committee Action | Positive |
| 2025-03-20 | House | Placed on Calendar 2nd Reading - Short Debate Senate Rule 4-4(7-8)/5-2; House Rule 31(8-9)/38/52 | Floor Process | Positive |
| 2025-03-26 | House | Second Reading - Short Debate Senate Rule 3-12(a)/5-4(a); House Rule 24(a)/40(b)/52(a)(1) | Floor Process | Positive |
| 2025-03-26 | House | Held on Calendar Order of Second Reading - Short Debate Senate Rule 4-4(7-8)/5-2; House Rule 31(8-9)/38/52 | Floor Process | — |
| 2025-04-08 | House | Added Co-SponsorRep. Camille Y. Lilly Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-04-11 | House | Rule 19(a) / Re-referred toRules Committee House Rule 19(a); Senate analog: Rule 3-9(a) | Deadlines & Re-referrals | Mild − |